THERACLION: UVA Cancer Center to Expand Use of Theraclion's HIFU System in Cancer Treatment Research
Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE, PEA-PME eligible), an innovative company specialized in echotherapy treatment (using High Intensity Focused Ultrasound or HIFU), announces